AJP - Heart and Circulatory Physiology, Vol 273, Issue 2 827-H836, Copyright © 1997 by American Physiological Society

ARTICLES

Role of ET and NO in resuscitative effect of diaspirin cross-linked hemoglobin after hemorrhage in rat

A. Gulati, A. P. Sen, A. C. Sharma and G. Singh
Department of Phamaceutics, University of Illinois at Chicago Health Sciences Center 60612, USA.

Diaspirin cross-linked hemoglobin (DCLHb) is a hemoglobin-based therapeutic agent that produces significant cardiovascular effects, possibly due to its actions on vasoactive substances, such as endothelin (ET) and nitric oxide (NO). We have studied the modulation of cardiovascular effects of DCLHb by an NO synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME), and an ETA-receptor antagonist, FR-139317, in hemorrhaged rats. Control rats resuscitated with vehicle [Ringer lactate (RL), 4 ml/kg iv] did not show any improvement in O2 consumption, base deficit, systemic hemodynamics, or regional blood flow after hemorrhage, and the rats survived for < 70 min. Administration of DCLHb (400 mg/kg iv) significantly improved O2 consumption, base deficit, systemic hemodynamics, and regional blood circulation after resuscitation, and the rats survived for > 120 min after hemorrhage. Plasma ET-1 and guanosine 3',5'-cyclic monophosphate (cGMP) concentrations increased after hemorrhage. DCLHb produced an increase in ET-1 and decreased cGMP concentrations in plasma. Pretreatment with L-NAME (10 mg/kg iv) or FR-139317 (4 mg/kg iv) attenuated the DCLHb-induced improvement in survival time, base deficit, systemic hemodynamics, and regional blood circulation. L-NAME (10 mg/kg iv) per se did not produce any resuscitative effect; therefore the NO mechanism may not be contributing toward the efficacy of DCLHb in hemorrhaged rats. However, FR-139317 attenuated the efficacy of DCLHb; therefore an increase in plasma ET-1 concentration by DCLHb may be contributing toward the efficacy of DCLHb in hemorrhage. Hemorrhage-induced increase in cGMP levels could be attenuated by L-NAME, but L-NAME was not effective in resuscitation of hemorrhaged rats, indicating a lack of role of NO in resuscitation. It is concluded that the ET mechanism is more important in the beneficial effect of DCLHb than the NO mechanism in hemorrhage.

This article has been cited by other articles:

				M. Kavdia and A. S. Popel Contribution of nNOS- and eNOS-derived NO to microvascular smooth muscle NO exposure J Appl Physiol, July 1, 2004; 97(1): 293 - 301. [Abstract] [Full Text] [PDF]

				J. H. Levy, L. T. Goodnough, P. E. Greilich, G. V. S. Parr, R. W. Stewart, I. Gratz, J. Wahr, J. Williams, M. E. Comunale, D. Doblar, et al. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: Results of a randomized, double-blind trial J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 35 - 42. [Abstract] [Full Text] [PDF]

				M. Kavdia, N. M. Tsoukias, and A. S. Popel Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2245 - H2253. [Abstract] [Full Text] [PDF]

				M. R. Forrest, A. H. Chester, and D. Royston The Effects of Diaspirin Cross-Linked Hemoglobin on the Tone of Human Saphenous Vein Anesth. Analg., February 1, 2001; 92(2): 324 - 328. [Abstract] [Full Text] [PDF]

				A. W. Sielenkamper, P. Yu, O. Eichelbronner, T. MacDonald, C. M. Martin, I. H. Chin-Yee, and W. J. Sibbald Diaspirin cross-linked Hb and norepinephrine prevent the sepsis-induced increase in critical O2 delivery Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1922 - H1930. [Abstract] [Full Text] [PDF]

				J. M. Stulak, L. A. Juncos, J. A. Haas, and J. C. Romero Systemic hemodynamics and renal function in hemorrhaged dogs resuscitated with cross-linked hemoglobin Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R28 - R33. [Abstract] [Full Text] [PDF]

				A. C. Sharma, B. G. Fogelson, S. I. Nawas, W. T. Vigneswaran, A. D. Sam II, K. J. Alden, J. L. Ferguson, and W. R. Law Elevated coronary endothelin-1 but not Nitric Oxide in diabetics during CABG Ann. Thorac. Surg., June 1, 1999; 67(6): 1659 - 1663. [Abstract] [Full Text] [PDF]

				A. Caron, P. Menu, B. Faivre-Fiorina, P. Labrude, A. I. Alayash, and C. Vigneron Cardiovascular and hemorheological effects of three modified human hemoglobin solutions in hemodiluted rabbits J Appl Physiol, February 1, 1999; 86(2): 541 - 548. [Abstract] [Full Text] [PDF]

				B. Faivre-Fiorina, A. Caron, C. Fassot, I. Fries, P. Menu, P. Labrude, and C. Vigneron Presence of hemoglobin inside aortic endothelial cells after cell-free hemoglobin administration in guinea pigs Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H766 - H770. [Abstract] [Full Text] [PDF]

				A. Rebel, J. A. Ulatowski, K. Joung, E. Bucci, R. J. Traystman, and R. C. Koehler Regional cerebral blood flow in cats with cross-linked hemoglobin transfusion during focal cerebral ischemia Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H832 - H841. [Abstract] [Full Text] [PDF]

				M. Kavdia, N. M. Tsoukias, and A. S. Popel Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2245 - H2253. [Abstract] [Full Text] [PDF]